Posts

GNS A WILD SWING TRADE OPPORTUNITY

$GNS Swing Trade Analysis – June 2025 Swing Trading Setup: $GNS (Genius Group Ltd.) Last updated: June 16, 2025 Context and Recent Price Action Recent Price Movement: $GNS has been highly volatile. After dropping 19.3% in a single day, it rebounded 37.95%, trading near $0.6179. However, some traders report it near $1.15 following a pullback from $0.91. For analysis, we’ll assume the price is near $1.00. Technical Levels: Support at $0.97–$1.00; resistance at $1.05, $1.25, $1.31, $1.40, $1.46–$1.50, $1.99, and $2.30. A break over $1.25 could signal continuation. Market Sentiment: Bullish sentiment on X (Twitter) suggests hopes for a short squeeze or gains if a $100M legal settlement occurs. These are speculative. Analyst Outlook: Wall Street analysts maintain a bearish 12-month forecast with unspecified targets, urging caution. What an Experienced Trader Might Do 1. Confirm the Setup Chart Patterns: Watch for bullish set...
Post a Comment
Read more

BOOM TIME

Explosive Swing Trade Setups: SRXH, BBLG, SOUN Explosive Swing Trade Setups: Health Stocks SRXH, BBLG, SOUN Not financial advice. Subject to error. Buckle up, traders! These health-focused small-caps are primed for explosive 50-100%+ gains in 1-4 weeks, perfect for aggressive swing traders chasing big returns like we’ve seen with CYN and MBRX. Using TradingView technicals and X sentiment, here are three health stocks with breakout potential, backed by fresh catalysts and low-float setups. Let’s dive in! SRx Health Solutions (SRXH) Why Explosive? This $40M health and wellness play (chronic disease care, infusion services) rebranded from Better Choice Company (April 30, 2025) after a Canadian merger. Q1 2025 earnings (May 15) showed a 90% EPS improvement (-$0.37 vs. -$3.70 YoY) and 54% narrower EBITDA loss (-$0.6M). A crypto treasury move (Bitcoin/Ethereum buys, $1.5M Solana-to-Ethereum shift) and new leadership (CEO/Chairman, June 11) f...
Post a Comment
Read more

BOOM TIME

Explosive Swing Trade Setups: Health Stocks SRXH, BBLG, SOUN Not financial advice. Subject to error. Buckle up, traders! These health-focused small-caps are primed for explosive 50-100%+ gains in 1-4 weeks, perfect for aggressive swing traders chasing big returns like we’ve seen with CYN and MBRX. Using TradingView technicals and X sentiment, here are three health stocks with breakout potential, backed by fresh catalysts and low-float setups. Let’s dive in! SRx Health Solutions (SRXH) Why Explosive? This $40M health and wellness play (chronic disease care, infusion services) rebranded from Better Choice Company (April 30, 2025) after a Canadian merger. Q1 2025 earnings (May 15) showed a 90% EPS improvement (-$0.37 vs. -$3.70 YoY) and 54% narrower EBITDA loss (-$0.6M). A crypto treasury move (Bitcoin/Ethereum buys, $1.5M Solana-to-Ethereum shift) and new leadership (CEO/Chairman, June 11) fuel hype. X posts (@buysellshort) call $0.90-$1...
Post a Comment
Read more

What's Popping?

I am noticing activity on SOUN SRHX BBLG GNS    ðŸŽ°
Post a Comment
Read more

MBRX Note

Post a Comment
Read more

MBRX Note

Important Note on Price Discrepancy ($0.3167 vs. $2.50) There’s been confusion around $MBRX’s share price due to a recent reverse split and a $5.9 million public offering . Here’s a breakdown: Pre-Split Price: Many older charts and screeners still reflect prices in the $2.40–$2.60 range . This data is before the company executed a reverse split and conducted a dilutive offering. Post-Split/Offering Price: As of June 26, 2025, $MBRX trades at ~$0.3167 , reflecting both the reverse split and dilution from the offering of 16.08 million shares at $0.37. This blog post uses the updated $0.3167 price to ensure real-time relevance for new traders and chart watchers. However, we also include a separate trade plan for those tracking the legacy $2.50 level to avoid confusion. $MBRX: A High-Risk, High-Reward Swing Trade Opportunity for Aggressive Traders Small-cap biotech stocks are a rollercoaster, but for traders chasing explosive 50–100%+ gains, Moleculin Biotech ( $MBRX ) is...
Post a Comment
Read more

MBRX

$MBRX: A High-Risk, High-Reward Swing Trade Opportunity for Aggressive Traders Small-cap biotech stocks are a rollercoaster, but for traders chasing explosive 50–100%+ gains, Moleculin Biotech ( $MBRX ) is making waves. With a low float, recent volume surges, and promising catalysts, $MBRX offers a compelling setup for aggressive swing traders willing to hold for 1–2 weeks—or longer if momentum builds. Here’s a deep dive into why $MBRX is worth watching, complete with technicals, catalysts, sentiment from X, and a precise trade plan. Why $MBRX? The Setup As of June 26, 2025, $MBRX trades at approximately $0.3167 (post-offering adjusted), with a float of ~12.79M shares and a market cap of $12–15M. Recent trading volume hit 11.47M shares in a single day—nearly matching the float—signaling intense retail interest and potential for sharp moves. High volatility (4.92% daily) and short interest (13.79%) make it a prime candidate for a short squeeze or catalyst-driven breakout. Techni...
Post a Comment
Read more